Deepak MBA - Dr Reddys CEO Council
| RDDA Stock | EUR 14.30 0.10 0.70% |
Insider
Deepak MBA is CEO Council of Dr Reddys Laboratories
| Age | 48 |
| Phone | 91 40 4900 2900 |
| Web | https://www.drreddys.com |
Dr Reddys Management Efficiency
The company has return on total asset (ROA) of 0.0949 % which means that it generated a profit of $0.0949 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1772 %, meaning that it generated $0.1772 on every $100 dollars invested by stockholders. Dr Reddys' management efficiency ratios could be used to measure how well Dr Reddys manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Aidan Murphy | Ipsen SA | 57 | |
| David Stark | Teva Pharmaceutical Industries | 54 | |
| Kathleen Veit | Teva Pharmaceutical Industries | N/A | |
| Akira Kato | Shionogi Co | N/A | |
| Haruo Naito | Eisai Co | 76 | |
| Sayoko Sasaki | Eisai Co | 55 | |
| David Loew | Ipsen SA | 56 | |
| Anders MD | Swedish Orphan Biovitrum | 67 | |
| John Keller | Shionogi Co | 58 | |
| Julien Meissonnier | Catalent | N/A | |
| Yoshimasa Kyokawa | Shionogi Co | N/A | |
| Susumu Mitsumori | Shionogi Co | N/A | |
| Yosuke Akita | Eisai Co | 58 | |
| Salvatore Alesci | Takeda Pharmaceutical | N/A | |
| Francois Garnier | Ipsen SA | 61 | |
| Gwenan White | Ipsen SA | N/A | |
| Torbjrn Hallberg | Swedish Orphan Biovitrum | 54 | |
| Sven Dethlefs | Teva Pharmaceutical Industries | 54 | |
| Eliyahu Kalif | Teva Pharmaceutical Industries | 50 | |
| Dominique Bery | Ipsen SA | 52 | |
| Philip Wood | Swedish Orphan Biovitrum | 55 | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0949 |
Dr Reddys Laboratories Leadership Team
Elected by the shareholders, the Dr Reddys' board of directors comprises two types of representatives: Dr Reddys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RDDA. The board's role is to monitor Dr Reddys' management team and ensure that shareholders' interests are well served. Dr Reddys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dr Reddys' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Parag Agarwal, CFO Council | ||
| Sanjay BTech, Global VP | ||
| Erez MBA, CEO Council | ||
| Gunupati BE, MD CoChairman | ||
| MS BTech, Chairman Council | ||
| MBA MBA, CEO Council | ||
| Deepak MBA, CEO Council |
RDDA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dr Reddys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0949 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 8.47 B | |||
| Shares Outstanding | 166.1 M | |||
| Shares Owned By Institutions | 10.37 % | |||
| Price To Earning | 23.95 X | |||
| Price To Book | 3.61 X | |||
| Price To Sales | 0.04 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in RDDA Stock
When determining whether Dr Reddys Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dr Reddys' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Reddys Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Reddys Laboratories Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.